Supplementary Figure S3 from Repurposing the DNA Labeling Agent EdU for Therapy against Heterogeneous Patient Glioblastoma

<p>Figure S3: (A) Number of mice bearing intracranial allografts of CT2A and xenografts of U251 cells, nontreated or treated with different doses of EdU or thymidine, showing different mortality observations. Mice bearing intracranial allografts of CT2A and xenografts of U251 cells showed body...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας:	Humeyra Kaanoglu (21903844) (author)
Άλλοι συγγραφείς:	Adebimpe Adefolaju (21903847) (author), Casey Fraley (21903850) (author), Mariah Shobande (21903853) (author), Rajaneekar Dasari (21903856) (author), Breanna Mann (21903859) (author), Noah Bell (21903862) (author), Stephen T. Keir (18724623) (author), Dominique Higgins (21903865) (author), David E. Kram (15110825) (author), Shawn D. Hingtgen (21903868) (author), Aziz Sancar (21903871) (author), Andrew B. Satterlee (21903874) (author)
Έκδοση:	2025
Θέματα:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Clinical Research and Trials Methods and Technology CNS Cancers Gliomas, Glioblastomas Dna Damage And Repair DNA damage Precision Medicine Preclinical Models Small Molecule Agents Translational Research
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Supplementary Figure S3 from Repurposing the DNA Labeling Agent EdU for Therapy against Heterogeneous Patient Glioblastoma

Παρόμοια τεκμήρια